Bi-allelic loss of NF1 gene function (NF1−/−) due to the somatic loss of heterozygosity (LOH) of the NF1 gene has been reported to be essential for MPNST development (10). This evidence concerns the gene NF1 and malignant peripheral nerve sheath tumor.